3 completed, 1 active not recruiting. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Active not recruiting 1 |
Follow Laryngeal Cancer: new trials by email Literature Review of Laryngeal Cancer trials Research Report on Laryngeal Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Thermotherapy for Locally Advanced Head and Neck Cancer Thermotherapy, radiotherapy - Head and Neck Cancer, Oropharyngeal Carcinoma | Phase 1 | Active not recruiting | Erasmus Medical Center | 2 | 2025-05-01 | 2026-09-02 |
| Pembrolizumab in Combination With CRT for LA-SCCHN pembrolizumab (MK-3475), Cisplatin, Radiation - Head and Neck Cancer, Squamous Cell Carcinoma | Phase 1 | Completed | Sanford Health | 59 | 2015-11-01 | 2025-10-07 |
| Resistance Training and Physical Functioning in Head and Neck Cancer Patients Nutrition Counseling, Resistance Training and Nutrition Counseling - Head and Neck Cancer, Pharyngeal Cancer | Phase 1 | Completed | University of Alabama at Birmingham | 18 | 2009-03-01 | 2023-10-18 |
| Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer Bortezomib (Velcade, PS-341), Cetuximab, Cisplatin - Carcinoma, Squamous, Head and Neck Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 3 | 2008-02-05 | 2019-12-17 |
Head and Neck Neoplasms (4) · Laryngeal Neoplasms (4) · Mouth Neoplasms (3) · Carcinoma, Squamous Cell (2) · Hypopharyngeal Neoplasms (2) · Oropharyngeal Neoplasms (2) · Pharyngeal Neoplasms (2) · Hyperthermia (1) · Laryngeal Diseases (1) · Squamous Cell Carcinoma of Head and Neck (1)
Neoplasms (4) · Neoplasms by Site (4) · Otorhinolaryngologic Diseases (4) · Otorhinolaryngologic Neoplasms (4) · Pharyngeal Diseases (4) · Respiratory Tract Diseases (4) · Respiratory Tract Neoplasms (4) · Stomatognathic Diseases (4) · Carcinoma (3) · Laryngeal Diseases (3) · Mouth Diseases (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3) · Neoplasms, Squamous Cell (2) · Pharyngeal Neoplasms (2)
Cisplatin (2) · Radiotherapy (2) · Bortezomib (1) · Cetuximab (1) · Diathermy (1) · Hyperthermia, Induced (1) · Nutritional Status (1) · Radiation (1) · Resistance Training (1) · pembrolizumab (1)
Erasmus Medical Center (1) · National Cancer Institute (NCI) (1) · Sanford Health (1) · University of Alabama at Birmingham (1)
United States (3) · Netherlands (1)
Carter Van Waes, M.D. (1) · Laura Q Rogers, MD, MPH (1) · Michiel Kroesen, MD, Dr. (1) · Steven F Powell, MD (1)